| ARCHETYPE ID | openEHR-EHR-OBSERVATION.mantoux_test_result.v0 |
|---|---|
| Concept | Mantoux test result |
| Description | The test result, including findings and interpretation, following administration of the Mantoux Tuberculin Skin Test (TST). |
| Use | Use to record the test result, including findings and interpretation, following administration of the Mantoux Tuberculin Skin Test (TST). |
| Purpose | To record thetest result, including findings and interpretation, following administration of the Mantoux Tuberculin Skin Test (TST). |
| References | Nayak S, Acharjya B. Mantoux test and its interpretation. Indian Dermatol Online J. 2012 Jan;3(1):2-6. doi: 10.4103/2229-5178.93479. PMID: 23130251; PMCID: PMC3481914. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481914/. |
| Copyright | © openEHR Foundation |
| Authors | Author name: Heather Leslie Organisation: Atomica Informatics Email: heather.leslie@atomicainformatics.com Date originally authored: 2012-11-21 |
| Other Details Language | Author name: Heather Leslie Organisation: Atomica Informatics Email: heather.leslie@atomicainformatics.com Date originally authored: 2012-11-21 |
| Other Details (Language Independent) |
|
| Keywords | TB, Mantoux, reaction, tuburculin, TST |
| Lifecycle | in_development |
| UID | 90e6342c-c561-40c9-8eda-b07da65e801a |
| Language used | en |
| Citeable Identifier | 1246.145.2562 |
| Revision Number | 0.0.1-alpha |
| protocol | |
| Rationale for interpretation | Rationale for interpretation: Rationale used to interpret the reaction. The criterion or classification as positive or negative takes into account two parameters: size of induration; and a mixture of patient's background risk of infection, including age, occupation and health conditions. For example: a patient with a HIV-positive status would have a different criteria for recording a positive Mantoux test than the general population. |
| Extension | Extension: Additional information required to capture local content or to align with other reference models/formalisms. For example: local information requirements or additional metadata to align with FHIR or CIMI equivalents. Include: All not explicitly excluded archetypes |
| data | |
| Diameter | Diameter: The measured diameter of the induration reaction. Property: Length Units: >=0.0 mm Limit decimal places: 0 |
| Clinical description | Clinical description: Narrative description about the Mantoux reaction findings. For example: noting the formation of vesicles, bullae, lymphangitis, ulceration and necrosis at the test site. |
| Interpretation | Interpretation: Clinical interpretation of the induration response. Choice of:
|
| Multimedia representation | Multimedia representation: Digital image, video or diagram representing the test result. Multiple formats are allowed but they should represent equivalent clinical content. Include: openEHR-EHR-CLUSTER.media_ |
| Comment | Comment: Additional narrative about the Mantoux test result, not captured in other fields. For example, 'suspicious of infection', 'suggestive of infection', 'consistent with past infection', '90% of patients have infection', and 'virtually all have infection'. http://rcpamanual.edu.au/index.php?option=com_content&view=article&id=80&Itemid=80 |
| events | |
| Any point-in-time event | Any point-in-time event: Default, unspecified point-in-time event which may be more explicitly defined in a template or at run-time. |
| Other contributors | Merrilyn Curtis, AnalyzeIT, Australia Sistine Barretto-Daniels, Ocean Informatics, Australia |
| Translators |